Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among people living with MS
TG Therapeutics, announced a collaboration with actress Christina Applegate to help raise awareness of multiple sclerosis (MS) and support meaningful conversations for those living with the disease.
Christina Applegate, who has been living with MS for 5 years, will lead the new national disease-awareness initiative designed to elevate the voices of people living with MS, highlight the realities, and explore what comes next, on their own terms.
The cornerstone of the campaign is www.NextInMS.com, a new platform developed to support people living with MS. Through Next In MSTM, Christina extends the same unfiltered honesty she has brought to her own experience into shared conversations with others living with MS. The platform will feature exclusive content including Christina’s personal perspectives on navigating life with MS, long-term decision-making, engaging with the healthcare system, and prioritizing quality of life while living with a chronic condition. It is expected to also include educational content from leading MS experts offering current insights on topics of interest to the MS community. Together, these efforts are intended to foster open, informed dialogue among people living with MS, caregivers, and healthcare professionals.
Read More: SalesTechStar Interview with Sahil Rekhi, Chief Revenue Officer at Graia
“MS isn’t something you neatly figure out and move on from — it’s messy, it’s unpredictable and some days it frankly just sucks,” said Christina Applegate. “I’ve always tried to be honest about that. Next In MS is about opening up those conversations, expanding our understanding and always being prepared for what’s next. I’m excited to be partnering with TG Therapeutics, and together hopefully we can reach more members of the MS community, cut through the noise and talk openly about the truths of living with MS — the challenging ones and the hopeful ones too.”
Michael S. Weiss, Chairman and Chief Executive Officer of TG Therapeutics, added, “Christina brings a level of openness and authenticity that resonates deeply with us at TG. We’re honored to collaborate with her as she shares her perspective and as we collectively look toward what’s next in MS. At TG Therapeutics, we remain committed to advancing innovation and supporting efforts that keep those living with MS at the center of everything we do.”
TG’s focus on advancing innovation in multiple sclerosis includes not only the development of novel therapies, but also a commitment to supporting resources that help people living with MS feel informed and empowered throughout their care journey.
Read More: Beyond CRM: How SalesTech is Shaping the Future of Deal Management?
